GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Net Margin %

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Net Margin % : 4.95% (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. GlaxoSmithKline Consumer Nigeria's Net Income for the three months ended in Jun. 2023 was ₦185 Mil. GlaxoSmithKline Consumer Nigeria's Revenue for the three months ended in Jun. 2023 was ₦3,732 Mil. Therefore, GlaxoSmithKline Consumer Nigeria's net margin for the quarter that ended in Jun. 2023 was 4.95%.

The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's Net Margin % or its related term are showing as below:

NSA:GLAXOSMITH' s Net Margin % Range Over the Past 10 Years
Min: 2.92   Med: 3.89   Max: 29.21
Current: 4.24


NSA:GLAXOSMITH's Net Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 3.225 vs NSA:GLAXOSMITH: 4.24

GlaxoSmithKline Consumer Nigeria Net Margin % Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Net Margin % Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.35 4.42 2.92 2.93 3.04

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.64 2.08 2.39 5.80 4.95

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Net Margin %

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Consumer Nigeria's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Net Margin % distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Net Margin % falls into.



GlaxoSmithKline Consumer Nigeria Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

GlaxoSmithKline Consumer Nigeria's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=771.146/25382.419
=3.04 %

GlaxoSmithKline Consumer Nigeria's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=184.551/3731.801
=4.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


GlaxoSmithKline Consumer Nigeria Net Margin % Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines